Study of AlucentNVS in Australia
Latest Information Update: 18 Aug 2023
At a glance
- Drugs Peripheral vascular disorder therapeutics Alucent Biomedical (Primary)
- Indications Arteriovenous fistula; Peripheral vascular disorders
- Focus Therapeutic Use
- Sponsors Alucent Biomedical
- 18 Aug 2023 New trial record
- 02 Aug 2023 According to a Alucent Biomedical media release, enrollment in this study is expected to conclude by the end of 2023.